Cadriometabolic Science encompasses research into obesity, diabetes, cardiovascular risk, metabolic syndrome and insulin resistance, cardiovascular physiology, vascular cell biology and cardiovascular disease including stroke, microangiopathies and clinical trials and reaches out across the wider UCL community to facilitate cutting-edge health science research and delivery.

Cardiovascular is also a clinical programme in UCL Partners, which will be Europe’s leading health-research powerhouse, and Cardiovscular Disease is a research theme of the UCL/University College London Hospitals NHS Foundation Trust Comprehensive Biomedical Research Centre.